Parenteral hydration no benefit for cancer care in hospices

November 28, 2012
Parenteral hydration no benefit for cancer care in hospices
For patients with advanced cancer in hospices, providing parenteral saline (1 liter per day) does not improve symptoms associated with dehydration, quality of life, or overall survival compared with placebo, according to a study published online Nov. 19 in the Journal of Clinical Oncology.

(HealthDay)—For patients with advanced cancer in hospices, providing parenteral saline (1 liter per day) does not improve symptoms associated with dehydration, quality of life, or overall survival compared with placebo, according to a study published online Nov. 19 in the Journal of Clinical Oncology.

To examine the effect of parenteral hydration in advanced in hospices, Eduardo Bruera, M.D., of the University of Texas MD Anderson Cancer Center in Houston, and colleagues conducted a double-blind, randomized, placebo-controlled study involving 129 patients with advanced cancer from six hospices who received either parenteral administration of 1 liter of normal saline per day or placebo (normal saline 100 milliliter per day) over a four-hour period.

At days four and seven of parenteral hydration, the researchers observed no significant differences between the two groups in the sum of four dehydration symptoms (fatigue, myoclonus, , and ). Similarly, no differences were observed in any of the five scales used to assess overall symptoms, delirium, myoclonus, fatigue, and dehydration. There was no significant difference in overall survival between the two groups (median, 21 versus 15 days; P = 0.83).

"Our study supports current hospice practice of not administering hydration routinely," the authors write. "Further studies are required to determine whether any subgroups, such as delirious patients or those with longer survival, would benefit from parenteral hydration."

Explore further: L-carnitine does not reduce cancer-related fatigue

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

L-carnitine does not reduce cancer-related fatigue

September 18, 2012
(HealthDay)—Patients with invasive malignancies who take L-carnitine supplements do not experience a reduction in fatigue, pain, or depression, according to research published online Sept. 17 in the Journal of Clinical ...

Vandetanib doesn't up survival in non-small-cell lung cancer

March 2, 2012
(HealthDay) -- Vandetanib does not improve overall survival for patients who have received previous treatment for advanced non-small-cell lung cancer (NSCLC), according to a study published online Feb. 27 in the Journal of ...

Adding ketamine to opioids doesn't reduce cancer pain

September 11, 2012
(HealthDay)—Using subcutaneously administered ketamine in a dose-escalating regimen as an adjunct to opioids and standard co-analgesics does not have any clinical benefit in relieving cancer pain, but it is associated with ...

Study says VeriStrat predicts response but not survival benefit from erlotinib

October 15, 2012
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit ...

Hospice visit number affects ability to die at home

June 27, 2012
(HealthDay) -- Hospice patients with cancer are more likely to be able to die in the setting of their choice if they receive at least one hospice visit per day during the first four days of hospice care, according to research ...

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.